Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
Published Online: 2008-09-?
Journal: The Lancet Neurology•Publisher: Elsevier BV
Authors: Ashley I Bush•Colin L Masters•Craig W Ritchie•David Ames•Henrik Zetterberg•Janet Wilson•John Harrison•Kaj Blennow•Lars Lannfelt•Ross Murdoch•Stellan Batsman•Steve Targum
